CD24 and ovarian carcinoma: As an example, a 3D‐nanopatterned microfluidic chip allowed for the detection, in 2‐μL plasma samples from ovarian cancer patients, of exosome subpopulations expressing CD24, EpCAM and FR‐α proteins as potential biomarkers for ovarian cancer.36